Literature DB >> 22156982

Arg77His and Trp187Arg are the most common mutations causing FXIII deficiency in Iran.

Peyman Eshghi1, Nader Cohan, Manigeh Lak, Majid Naderi, Flora Peyvandi, Marzia Menegatti, Mehran Karimi.   

Abstract

The aim of this study was to review the literature for the genetic mutations causing inherited factoe XIII (FXIII) deficiency in patients from Iran, where the consanguineous marriage is common. Data were collected from 30 patients (18 males and 12 females) with FXIII deficiency, from 26 unrelated families. Data of mutation analysis were obtained from 2 previously published studies. A total of 7 mutations consisting of 5 new mutations and 2 previously reported mutations were identified. Of the 5 novel missense mutations, 2, Arg77His and Trp187Arg, were the most common in Iranian FXIII-deficient patients. In regions like Iran with high rate of consanguineous marriages, the identification of common mutations in disease like severe FXIII deficiency increases the capacity to make a precise screening and diagnosis assays to screen and diagnose families with high risk of FXIII deficiency for prevention of clinical complications in them.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22156982     DOI: 10.1177/1076029611412363

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  5 in total

1.  Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency.

Authors:  Majid Naderi; Akbar Dorgalaleh; Shaban Alizadeh; Shadi Tabibian; Soudabeh Hosseini; Morteza Shamsizadeh; Taregh Bamedi
Journal:  Int J Hematol       Date:  2014-09-18       Impact factor: 2.490

Review 2.  State of the art in factor XIII laboratory assessment.

Authors:  Michael A Durda; Alisa S Wolberg; Bryce A Kerlin
Journal:  Transfus Apher Sci       Date:  2018-08-04       Impact factor: 1.764

Review 3.  How to Assess Founder Effect in Patients with Congenital Factor XIII Deficiency.

Authors:  Hojat Shahraki; Akbar Dorgalaleh; Majid Fathi; Shadi Tabibian; Shahram Teimourian; Hasan Mollanoori; Alireza Khiabani; Farhad Zaker
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-10-01

Review 4.  Current understanding in diagnosis and management of factor XIII deficiency.

Authors:  M Naderi; A Dorgalaleh; Sh Tabibian; Sh Alizadeh; P Eshghi; Gh Solaimani
Journal:  Iran J Ped Hematol Oncol       Date:  2013-10-22

5.  Postpartum Hemorrhage in Heterozygote Factor XIII Deficient Women Compared With Healthy Women. A Cross-Sectional Experience From Iran.

Authors:  Majid Naderi; Ilia Mirzaei; Saeedeh Yaghoubi; Ida Milani; Nader Cohan
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.